Por: RTTNews Health January 09, 2023
Ocugen () reported positive results from the Phase 2/3, observer-blind, immuno-bridging and broadening study of its COVID-19 vaccine candidate, COVAXIN. The study met both co-primary endpoints with robust immune responses. COVAXIN has been demonstrated in clinical trials to generate a broader immune response against the whole virus covering important antigens such as S-protein, RBD, and N-protein. Also, the trials have showed that TLR7/8 agonist... + full article
MarketWatch USA Politics January 09, 2023
Moderna provided the update in advance of the company’s presentation at the annual J.P. Morgan Healthcare Conference in San Francisco. Separately, CureVac said preliminary data from its early stage trial for its COVID and seasonal flu shots had positive results to advance to... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
RTTNews USA Health December 28, 2022
Penny stocks, though highly volatile, could be an attractive addition to an investor's portfolio.Here are some of the biotech penny stocks that delivered triple-digit gains in 2022.ADMA Biologics Inc. ()It's been a banner year for ADMA, with its share price having... + más
Bob Penny, 'Sweet Home Alabama' and 'Forrest Gump' actor, dead at 87 | Fox News
Seahawks RB Rashaad Penny sidelined for rest of season | ABC News
Portland Press Herald USA Sports December 17, 2022
Bonny Eagle’s Julia Pendleton competes in the long jump Tuesday during an indoor track meet at the University of Southern Maine. USM prohibits the use of spikes during regular-season meets. “It’s a pretty big disadvantage not having spikes coming out of the blocks,” says... + más
Indoor track: Athletes to watch in southern Maine | Portland Press Herald
Indoor track: Teams to watch in southern Maine | Portland Press Herald
ABC7 USA Health December 01, 2022
treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with certain serious adverse events.Lecanemab has become one of the first experimental dementia drugs to appear to slow the progression of cognitive... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia | CNBC
RTTNews USA Health November 03, 2022
Parathyroid hormone plays a critical role in controlling calcium, phosphate and calcitriol (active vitamin D) levels in the blood and bone. Hypoparathyroidism is a rare endocrine disorder characterized by deficient or absent parathyroid hormone and it affects over 200,000 people... + más
Australians petition to put Steve Irwin on new currency, replacing Queen Elizabeth | New York Post
Stock market 'on cusp' of important test: Watch this S&P 500 level if 2022 low gives way, says RBC | MarketWatch
CNBC USA Health September 28, 2022
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022.Vanessa Leroy Bloomberg Getty Images vaccination is linked to a slight increase in... + más
New study confirms that COVID-19 vaccines can temporarily affect menstruation | ABC News
Study links Covid-19 vaccination to small, temporary change in menstrual cycle | CNN
RTTNews USA Health September 24, 2022
Pacira BioSciences, Inc. () announced Wednesday positive topline results from its Phase 3 study of EXPAREL as a single-dose sciatic nerve block in the popliteal fossa for postsurgical regional analgesia in patients undergoing bunionectomy.EXPAREL achieved the study's... + más
Prometheus Hits New High | RTTNews
Placentas in COVID-positive pregnant women show injury with blood circulation and clotting | Chicago Tribune
About iurex | Privacy Policy | Disclaimer |